| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,814 |
5,212 |
$286K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,819 |
3,955 |
$258K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,538 |
2,093 |
$172K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,112 |
2,759 |
$153K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
404 |
378 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,000 |
925 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
472 |
211 |
$3K |
| 87428 |
|
26 |
24 |
$1K |
| 69210 |
|
13 |
12 |
$564.36 |
| 81003 |
|
15 |
12 |
$14.44 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
14 |
14 |
$0.90 |
| 99000 |
|
430 |
413 |
$0.00 |
| 99072 |
|
280 |
239 |
$0.00 |